Takeda Pharmaceutical (TAK) Dividends Paid - Common (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Dividends Paid - Common of -$941.9 million for Q2 2026, up 6.2% year-over-year from -$886.9 million in Q2 2025, and down 124.02% quarter-over-quarter from $3.9 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Dividends Paid - Common (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Dividends Paid - Common history runs 9 years deep, the most recent figure standing at -$941.9 million for Q2 2026.
- In Q2 2026, Dividends Paid - Common rose 6.2% year-over-year to -$941.9 million; the TTM figure through Jun 2026 stood at $2.0 billion (up 3.63% YoY), while the FY2026 annual figure was $2.1 billion, up 4.11% from the prior year.
- Dividends Paid - Common for Q2 2026 stood at -$941.9 million, down from $3.9 billion in the prior quarter.
- The five-year high for Dividends Paid - Common was $4.8 billion in Q1 2022, with the low at -$1.0 billion in Q2 2025.
- The 5-year median for Dividends Paid - Common is -$483.9 million (2022), against an average of $653.2 million.
- Peak annual rise in Dividends Paid - Common reached 22.14% in 2023, while the deepest fall reached 13.71% in 2023.
- Takeda Pharmaceutical's Dividends Paid - Common stood at -$913.0 million in 2022, then dropped by 2.44% to -$935.3 million in 2023, then dropped by 2.29% to -$956.7 million in 2024, then decreased by 1.22% to -$968.4 million in 2025, then grew by 2.74% to -$941.9 million in 2026.
- Business Quant data shows TAK's Dividends Paid - Common at -$941.9 million in Q2 2026, $3.9 billion in Q1 2026, and -$968.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 223.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -941.91 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 139.80 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -941.91 Mn |
| Jun 30, 2026 | -941.91 Mn |
| Mar 31, 2026 | 3.92 Bn |
| Mar 31, 2026 | 3.92 Bn |
| Dec 31, 2025 | -968.40 Mn |
| Dec 31, 2025 | -968.40 Mn |
| Sep 30, 2025 | -59.64 Mn |
| Sep 30, 2025 | -59.64 Mn |
| Jun 30, 2025 | -1.00 Bn |
| Jun 30, 2025 | -1.00 Bn |
| Mar 31, 2025 | 3.91 Bn |
| Mar 31, 2025 | 3.91 Bn |
| Dec 31, 2024 | -956.74 Mn |
| Dec 31, 2024 | -956.74 Mn |
| Sep 30, 2024 | -61.67 Mn |
| Sep 30, 2024 | -61.67 Mn |
| Jun 30, 2024 | -887.20 Mn |
| Jun 30, 2024 | -887.20 Mn |
| Mar 31, 2024 | 3.82 Bn |
| Mar 31, 2024 | 3.82 Bn |